HIGH POINT, N.C., March 21, 2014 – High Point University associate professor of physiology Dr. James Smoliga recently published his research on the development of a resveratrol lozenge in the peer reviewed journal, “PLOS One.”
Resveratrol is an anti-oxidant found in red wine and is believed to be responsible for the cardiovascular benefits of red wine. In the research, Smoliga, along with researchers at Wilmore Labs and the University of Texas Health Science Center at San Antonio, found by dissolving resveratrol in sugars, the anti-oxidant could be administered to the blood stream through a lozenge.
“From this, we can perform larger studies exploring the use of resveratrol lozenges,” says Smoliga. “Resveratrol pills are sometimes, though not always, reported to have side effects on the GI tract, so this lozenge can hopefully eliminate that. Additionally, the lozenge allows resveratrol to get into the system very rapidly, which may expand the clinical applications it can be used for.”
An online version of the article can be found here: http://dx.plos.org/10.1371/journal.pone.0090131